Opened delivery carton with labelled clear vial cases and cardboard packing context
Opened delivery carton. Bubble wrap and packing material were moved aside for visibility in these photographs.

Start with what arrived

Connect the packaging to the records.

Packaging can show visible labels and codes. The records must establish how those packages connect to the tested sample and named production batch.

Download the TEKMERIS Protocol (PDF) →Seven-market overview; not a peptide-specific laboratory standard.

Tamper-evident packaging. Serialised TEKMERIS seals.
For an agreed future production batch, TEKMERIS oversees tamper-evident packaging and the attachment of a uniquely numbered seal to each covered packet or carton. Each seal number links that package to the dated record of the production activity and sealing observed. Existing stock cannot be retrospectively witnessed.

  1. Tested sampleWhat was selected and tested?
  2. Production batchWhat links the sample to this batch?
  3. Exact sealed packagesWhich serials were assigned?

The TEKMERIS service

What the TEKMERIS seal adds.

A controlled physical marking

Individually identified tamper-evident seals connect the exact assigned packages to the agreed observation record. Factory staff or equipment may apply them under direct TEKMERIS observation and control. The manifest records actual assignments, including non-sequential serials; a range alone does not define coverage.

A dated account of what was seen

The record identifies the production batch, attendance date, scope, observer notes and limitations. TEKMERIS’s observation reference is separate from the manufacturer’s batch number and the laboratory’s sample ID. Sealing is not laboratory testing, tamper-proof protection or a guarantee of contents or safety.

Design concepts — not issued client materials
Dossier, package-seal and facility-badge concepts from the seven-market Protocol. These are illustrative designs, not completed engagements or live registry features.
Design concepts for a TEKMERIS dossier, package seal and facility-visit badge; not issued client materials

View the fictional observation and sealing report →

The demonstration uses olive oil. It is not a completed peptide engagement or a live example of all proposed registry features.

Fictional example — no real supplier or TEKMERIS engagement

What can a COA tell you, and what must you check separately?

This invented document illustrates the fields a buyer may encounter. Every identity, reference and result below is fictional. It is not a laboratory report, a real product result or evidence of a TEKMERIS engagement.

FICTIONAL / ILLUSTRATIVE · NOT A REAL CERTIFICATE
Illustrative Laboratory · fictional identity

Certificate of analysis mock-up

Report reference · fictionalDEMO-R17
Client · fictional
Example Buyer
Listed supplier / manufacturer · fictional
Example Peptide Manufacturer
Sample ID · fictional
DEMO-S04
Listed production batch · fictional
DEMO-B12
Illustrative analytical entries — no tests were performed
AnalysisIllustrative methodFictional result
IdentityMass spectrometryIllustrative match
Chromatographic purityHPLC98.7% · invented
Content / assayNot includedNot reported
Sterility / endotoxinsNot includedNot reported

FICTIONAL / ILLUSTRATIVE · No laboratory, client, producer, sample, batch, analysis or result shown here is real. This mock-up cannot be used to verify goods.

How to verify a peptide COA: five evidence checks.

  1. 01

    Confirm the report

    Check the laboratory and report reference through the issuer’s independently found website or contact details. Read the sample ID, methods, dates and limits. A supplier’s PDF or QR code alone is not issuer confirmation.

  2. 02

    Trace the sample

    Who selected it, from which stock and when? Ask for selection, dispatch and laboratory-receipt records. A sample chain of custody describes those handovers; a printed code does not establish them.

  3. 03

    Identify the production batch

    Compare the peptide batch number across the report, production and sample records. Ask what supports the relationship. A matching code is a starting point, not proof of the full physical link.

  4. 04

    Find the exact package

    Check the assigned serial manifest, including non-sequential serials. Confirm the packaging level: a sealed carton does not mean every inner vial carries its own seal.

  5. 05

    Read the dated record

    Compare scope, date, observer notes and physical seal condition. Distinguish TEKMERIS observations, supplied information and independently confirmed facts. Record any unsupported link.

For practice and pharmacy purchasing teams

Build a clear evidence brief for your team.

For professional purchasing teams, the key question is what connects the tested sample to the production batch and the exact packages. Agree the questions, site access and proposed observation before production begins.

Define the work before production

Commission a prospective observation of agreed activity at a named site, subject to acceptance and access. TEKMERIS records the attendance date, defined production batch, observed activity, exact covered packaging and seal assignments, together with unavailable evidence and scope limitations.

Prepare an evidence brief for leadership

Use the fictional report to discuss the format and proposed scope with your team; it is not evidence for a purchasing decision. An issued report distinguishes observations from supplied information and independently confirmed facts. Optional laboratory evidence remains separate.

Package coverage and limits

A seal covers only the explicitly assigned packaging level. Sealing a carton does not mean each inner vial has an individual seal or separate coverage. TEKMERIS observation is not GMP certification, regulatory approval, a purchasing recommendation or a guarantee of clinical safety.

Client responsibilities

Each client remains responsible for applicable local rules on import, compounding, prescribing, supply, advertising and use, as well as its own professional and procurement decisions.

Optional independent evidence

Check what the laboratory tested.

Choose the laboratory and tests

The client selects an independent laboratory or requests a TEKMERIS laboratory recommendation. Testing is optional and separately charged to the client.

Agree on the tests, methods and limits with the laboratory; there is no universal fixed panel. A COA may report some or all of the analyses below. Check the issued report.

Sample dispatch and custody

TEKMERIS Global does not physically store or take custody of peptide products.

The factory packages and dispatches identified samples directly to the selected laboratory under the agreed instructions. TEKMERIS may coordinate those instructions. Read the custody rule and laboratory workflow.

Identity and chromatographic purity
Identity evidence, such as mass spectrometry where appropriate, answers a different question from a chromatographic purity percentage.
Content or assay
What quantity or concentration was measured, by which method? Do not substitute a purity percentage for a content result.
Endotoxins, sterility and microbial limits
These are distinct tests. Check which was ordered and the reported specification; one result is not interchangeable with another.
Solvents, metals and storage
Where relevant, ask about named analytes, limits and specified storage/transport conditions. A storage claim also needs appropriate records.

A laboratory report is sample-specific; it does not test every sealed package or by itself establish safety. Where none is available, state “No laboratory report recorded”. An observation engagement can be completed without testing, subject to its other agreed requirements.

China peptide supplier due diligence

Can the observer attend the next production batch?

Confirm site access

Ask who manufactures the material, at which site, and what activity and records can be observed. Refusal or limited access calls for clarification and may affect your decision; it is not proof of dishonesty.

Enquire about the next batch

Whether researching a small order or a production-scale order, use the same evidence questions. Buyers, producers and clinics may enquire about TEKMERIS’s scoped observation, subject to lawful scope, access, competence and conflict checks.

Service boundaries

TEKMERIS does not sell, source or broker peptides, select or introduce suppliers, recommend purchases or provide medical advice. TEKMERIS Global does not physically store or take custody of peptide products.

Before you enquire.

I already have the stock. What can I check?

Compare the report, all package labels and supplied selection, dispatch and production records. Ask the issuer to confirm its report. TEKMERIS cannot retrospectively witness completed production; an enquiry about the next batch must be made before the agreed activity.

Does a genuine COA cover every package?

It describes its identified sample and tests. Supporting records must establish the sample-to-batch and package relationships. Even a documented link does not mean every package was individually tested or guarantee quality, safety or legality.

Can a producer commission observation of its own batch?

Yes, subject to scope and conflict checks. Fees pay for the agreed work, not a favourable finding. Submission starts a scope discussion; it does not authorise a site visit.

What can a TEKMERIS seal scan show now?

The current TEKMERIS lookup provides existing record information, including observation reference and seal status. It does not authenticate third-party COAs or inspect the physical seal. Richer demonstration summaries and the complete report-request experience are proposed; full-report disclosure requires permission.

Plan the observation before the next production batch.

Tell us the site, proposed activity and timing. We will discuss whether a defined observation and sealing scope is possible.

By TEKMERIS Global · Updated